103 related articles for article (PubMed ID: 27372517)
1. [Choice of initial regimen for antiretroviral-naïve HIV patients: Analysis of motivation].
Rouveix E; Mortier E; Beauchet A; Dupont C; Gerbe J; Daneluzzi V; Brazille P; Berthe H; Zucman D; Genet P; Simonpoli AM; de Truchis P;
Rev Med Interne; 2016 Dec; 37(12):796-801. PubMed ID: 27372517
[TBL] [Abstract][Full Text] [Related]
2. Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study.
Dragovic G; Smith CJ; Jevtovic D; Dimitrijevic B; Kusic J; Youle M; Johnson MA
BMC Infect Dis; 2016 Mar; 16():106. PubMed ID: 26939611
[TBL] [Abstract][Full Text] [Related]
3. Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France.
Pugliese P; Joly V; Valantin MA; Cotte L; Huleux T; Allavena C; Reynes J; Poizot-Martin I; Bani-Sadr F; Cuzin L;
Med Mal Infect; 2019 Jun; 49(4):264-269. PubMed ID: 30409541
[TBL] [Abstract][Full Text] [Related]
4. [Initial antiretroviral prescriptions in patients with HIV. Second semester 1994-second semester 1996].
Courtial-Destembert S; Nadal JM; Bourdillon F; Cavaignac L; Tchakamian S
Presse Med; 1998 May 23-30; 27(19):905-8. PubMed ID: 9767850
[TBL] [Abstract][Full Text] [Related]
5. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection.
Fischl MA
AIDS; 1999 Sep; 13 Suppl 1():S49-59. PubMed ID: 10546785
[TBL] [Abstract][Full Text] [Related]
7. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study.
De Salvador-Guillouët F; Sakarovitch C; Durant J; Risso K; Demonchy E; Roger PM; Fontas E
PLoS One; 2015; 10(10):e0140519. PubMed ID: 26485149
[TBL] [Abstract][Full Text] [Related]
10. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.
Suárez-García I; González J; Berenguer J; García F; Portilla J; Muga R; Moreno S; Jarrín I;
Enferm Infecc Microbiol Clin (Engl Ed); 2019 Nov; 37(9):580-587. PubMed ID: 30982676
[TBL] [Abstract][Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
13. Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes.
Elzi L; Erb S; Furrer H; Ledergerber B; Cavassini M; Hirschel B; Vernazza P; Bernasconi E; Weber R; Battegay M;
Arch Intern Med; 2012 Sep; 172(17):1313-21. PubMed ID: 22892835
[TBL] [Abstract][Full Text] [Related]
14. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
de Monteynard LA; Dray-Spira R; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Gilquin J; Rey D; Simon A; Pavie J; Mahamat A; Matheron S; Costagliola D; Abgrall S;
PLoS One; 2015; 10(3):e0118492. PubMed ID: 25734445
[TBL] [Abstract][Full Text] [Related]
15. [Long-term efficacy of second-line treatment of HIV infection after class change following virological failure on protease inhibitor-based therapy].
Brunner J; Seybold U; Gunsenheimer-Bartmeyer B; Hamouda O; Bogner JR;
Dtsch Med Wochenschr; 2010 Jun; 135(23):1166-70. PubMed ID: 20514595
[TBL] [Abstract][Full Text] [Related]
16. [Non-antiretroviral drugs uses among HIV-infected persons receiving antiretroviral therapy in Senegal: Costs and factors associated with prescription].
Diouf A; Youbong TJ; Maynart M; Ndoye M; Diéye FL; Ndiaye NA; Koita-Fall MB; Ndiaye B; Seydi M
Rev Epidemiol Sante Publique; 2017 Aug; 65(4):295-300. PubMed ID: 28502580
[TBL] [Abstract][Full Text] [Related]
17. Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.
Duvivier C; Ghosn J; Assoumou L; Soulié C; Peytavin G; Calvez V; Génin MA; Molina JM; Bouchaud O; Katlama C; Costagliola D;
J Antimicrob Chemother; 2008 Oct; 62(4):797-808. PubMed ID: 18641035
[TBL] [Abstract][Full Text] [Related]
18. Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naïve patients starting cART after January 1, 2000.
Mocroft ; Horban ; Clumeck ; Stellbrink ; Monforte dA; Zilmer ; Kirk ; Gatell ; Phillips ; Lundgren ;
HIV Clin Trials; 2006; 7(6):271-84. PubMed ID: 17208897
[TBL] [Abstract][Full Text] [Related]
19. The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.
Di Biagio A; Rusconi S; Marzocchetti A; Signori A; Schiavetti I; Bruzzone B; Monno L; Punzi G; Colao MG; Penco G; Zazzi M; De Luca A;
J Med Virol; 2014 Oct; 86(10):1648-55. PubMed ID: 25042976
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
